Treatment measures in rheumatology: An overview of the use of targeted biologic therapies

Hdl Handle:
http://hdl.handle.net/10147/600497
Title:
Treatment measures in rheumatology: An overview of the use of targeted biologic therapies
Authors:
Loughlin, Ciara
Publisher:
Nursing in General Practice
Journal:
Nursing in General Practice
Issue Date:
Feb-2016
URI:
http://hdl.handle.net/10147/600497
Abstract:
There have been many exciting developments in rheumatology over the last two decades. A greater understanding of the functioning of the immune system in rheumatologic disorders has resulted in the development of targeted biologic therapies for patients.1 Biologic therapies represent a new kind of treatment for patients with a wide range of rheumatologic conditions such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE). Traditional therapies such as methotrexate, salazopyrine, plaquenil and arava are still very much part of the patients prescribed program with methotrexate remaining the first line treatment used in the management of inflammatory arthritis. However the advances in molecular biology have led to an array of new treatment approaches to inflammatory arthritis.2
Item Type:
Article
Language:
en
Keywords:
RHEUMATOLOGY; MOLECULAR BIOLOGY

Full metadata record

DC FieldValue Language
dc.contributor.authorLoughlin, Ciaraen
dc.date.accessioned2016-03-02T15:03:32Zen
dc.date.available2016-03-02T15:03:32Zen
dc.date.issued2016-02en
dc.identifier.urihttp://hdl.handle.net/10147/600497en
dc.description.abstractThere have been many exciting developments in rheumatology over the last two decades. A greater understanding of the functioning of the immune system in rheumatologic disorders has resulted in the development of targeted biologic therapies for patients.1 Biologic therapies represent a new kind of treatment for patients with a wide range of rheumatologic conditions such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE). Traditional therapies such as methotrexate, salazopyrine, plaquenil and arava are still very much part of the patients prescribed program with methotrexate remaining the first line treatment used in the management of inflammatory arthritis. However the advances in molecular biology have led to an array of new treatment approaches to inflammatory arthritis.2en
dc.language.isoenen
dc.publisherNursing in General Practiceen
dc.subjectRHEUMATOLOGYen
dc.subjectMOLECULAR BIOLOGYen
dc.titleTreatment measures in rheumatology: An overview of the use of targeted biologic therapiesen
dc.typeArticleen
dc.identifier.journalNursing in General Practiceen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.